The study, which was recently published in BMC Bioinformatics, was conducted by researchers at Nemours/Alfred I. duPont Hospital for Children and Genome Profiling LLC (GenPro), a biotech start-up from a University of Delaware molecular biologist named Adam Marsh’s company.
Symptoms of spastic CP include jerky movements, muscle stiffness and muscle tightness that can affect posture, make movement difficult, and cause affected children to be less active.
The Centers for Disease Control and Prevention (CDC) estimate that 1 in every 323 children has CP, making it the most common physical disability in children.
